Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324245 · ClinicalTrials.gov registry record · NA
Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01324245 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 45 participants.
The verdict
NCT01324245, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The kidney plays a crucial role in maintaining salt balance by two opposing physiological mechanisms: the renal dopaminergic system which enhances salt excretion and the renin-angiotensin system (RAS) which causes salt retention. Salt-sensitive hypertension occurs when this balance is altered or abnormal. We hypothesized that this balance is influenced by salt intake: therefore dietary salt affects the natriuretic response to the renal dopaminergic agonist Fenoldopam, and the Angiotensin Converting Enzyme inhibitor, Enalapril. In this trial we study normal salt balance mechanisms in salt resistant adults with normal blood pressure.
Interventions
- DRUG Fenoldopam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2002-11 |
| Est. Completion | 2006-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324245
The ClinicalTrials.gov registry entry for NCT01324245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fenoldopam is the first listed.
NCT01324245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324245 about?
NCT01324245 is a clinical study titled "Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet". The kidney plays a crucial role in maintaining salt balance by two opposing physiological mechanisms: the renal dopaminergic system which enhances salt excretion and the renin-angiotensin system (RAS) which causes salt retention. Salt-sensitive hypertension occurs when this balance is altered or abn...
What is the current status of trial NCT01324245?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2002-11. Estimated completion is 2006-05.
What interventions are being tested in trial NCT01324245?
The interventions under investigation include: Fenoldopam (DRUG).
Who is sponsoring clinical trial NCT01324245?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.